Ag+ Seeds Co.

CombinatoRx Raises $40M In Series C To Fund Clinical Trials.
BIOWORLD Today; 11/4/2009; 963 words; ...to date - $2.5 million in an initial seed round, $15.1 million in its Series B...signed a three-year agreement with Sosei Co. Ltd., of Tokyo, to discover combination...Carlsbad, Calif.; Private Life Biomed AG, of Bach, Switzerland; CDIB BioScience...

NewCo News: Novartis Deal Brings Synosia Its Sixth CNS Compound.
BIOWORLD Today; 11/3/2009; 1110 words; ...and an option for a seventh from Novartis AG. The ability to obtain access to "clinically...of mood disorders. Tokyo-based Eisai Co. Ltd. holds worldwide rights to the drug...The company raised $2.5 million in seed funding from Versant, Abingworth Management...

NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes.
BIOWORLD Today; 11/3/2009; 891 words; ...and new investor Hatteras Venture Partners co-led the round. The money should last...Viamet subsisted on about $500,000 in seed funding provided by Intersouth, which incubated...targets. Lotensin (benazepril HCl, Novartis AG) and other angiotensin converting enzyme...

Other News To Note.
BIOWORLD Today; 11/3/2009; 1064 words; ...Ambrilia said. o Evotec AG, of Hamburg, Germany...disclosed. o Genexine Co. Ltd. and Dong-A Pharmaceutical...collaboration covering co-commercialization of...development at Dong-A and co-development of second...be at the forefront of seed supply into the future...

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs.
BIOWORLD Today; 11/3/2009; 1322 words; Staff Writer Seed investors in GlycoVaxyn AG returned to provide CHF11...corporate development and a company co-founder, told BioWorld Today the two seed investors from a year ago gained...development, is another GlycoVaxyn co-founder. He was an inventor...